Skip to main content
Rural Health Information Hub

Rural Health
Resources by Topic: Prescription drug misuse

Association of Pharmaceutical Industry Marketing of Opioid Products With Mortality From Opioid-Related Overdoses
Highlights a study on the correlation between the marketing of opioids and opioid overdose mortality at a county-level. Breaks down data by participants' age, census region, and metro versus nonmetro location, among other factors.
Author(s): Scott E. Hadland, Ariadne Rivera-Aguirre, Brandon D. L. Marshall, Magdalena Cerdá
Citation: JAMA Network Open, 2(1)
Date: 01/2019
Type: Document
view details
The SUPPORT for Patients and Communities Act (P.L.115-271): Medicare Provisions
Provides a section-by-section description of Medicare provisions in the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (SUPPORT Act). Addresses rural in two sections: Section 6083 seeks to expand access to addiction treatment in Federally Qualified Health Centers and Rural Health Clinics by paying for training costs to obtain a DATA waiver to furnish OUD treatment; Section 6042 authorizes a demonstration project testing expanded access to MAT drugs through teams with a primary care provider.
Date: 01/2019
Type: Document
Sponsoring organization: Congressional Research Service
view details
Drug and Opioid-Involved Overdose Deaths - United States, 2013-2017
Reports on the annual number and age-adjusted rate of drug overdose deaths, analyzing data between both 2013 and 2017 and also between 2016 and 2017. Includes all opioids and prescription opioids, and heroin and synthetic opioids other than methadone. Includes statistics with breakdowns by metropolitan, micropolitan, and noncore areas in addition to 34 states.
Author(s): Lawrence Scholl, Puja Seth, Mbabazi Kariisa, Nana Wilson, Grant Baldwin
Citation: MMWR (Morbidity and Mortality Weekly Report), 67(5152), 1419-1427
Date: 01/2019
Type: Document
Sponsoring organization: Centers for Disease Control and Prevention
view details
SOAR Impact Report 2019
Annual report from Shaping Our Appalachian Region, a nonprofit organization dedicated to expanding job creation, improving quality of life, and enhancing opportunity, innovation, and identity in Appalachian Kentucky. Includes a section on the UNITE Rural Health Opioid Program, a Kentucky River Region initiative begun in January 2019 with the goal of reducing morbidity and mortality related to opioid use disorders.
Date: 2019
Type: Document
Sponsoring organization: Shaping Our Appalachian Region
view details
Tribal Opioid Response: Healing Our Nations Together - National Strategic Agenda
Addresses the tribal opioid epidemic, with recommendations based on input from tribal policymakers, service providers, and community members. Offers insights from experts, feedback from people with opioid use disorder, and tips for creating a plan to collect and analyze opioid data from local communities.
Date: 2019
Type: Document
Sponsoring organizations: National Indian Health Board, Northwest Portland Area Indian Health Board
view details
Opioid Epidemic in the United States: Empirical Trends, and A Literature Review of Social Determinants and Epidemiological, Pain Management, and Treatment Patterns
Analyzes trends in U.S. drug overdose mortality by key social determinants. Reports findings from a selective review of the literature on how the opioid crisis is impacting different segments of the population, including rural residents.
Author(s): Gopal K. Singh, Isaac E. Kim, Mehrete Girmay, et al.
Citation: International Journal of Maternal and Child Health and AIDS, 8(2), 89-100
Date: 2019
Type: Document
view details
The Relationship Between Rural Setting and Health: Factors that Influence Individuals With or at Risk of CVD - A Summary of the Literature
Describes current literature on rural challenges and opportunities, including cardiovascular risk due to obesity, lack of access to healthcare, workforce shortages, importance of paramedics and community health workers, telehealth and broadband, and impact of the substance use disorder epidemic. Intended to help stakeholders understand the causes of health disparities and to support action to improve the health of rural communities.
Date: 2019
Type: Document
Sponsoring organization: American Heart Association
view details
Comparing Buprenorphine-Prescribing Physicians Across Nonmetropolitan and Metropolitan Areas in the United States
Highlights a study comparing buprenorphine prescribing rates between metro and nonmetro areas. Looks at physician treatment practices, characteristics, and practice location.
Author(s): Lewei (Allison) Lin, Hannah K. Knudsen
Citation: Annals of Family Medicine, 17(3), 212-220
Date: 2019
Type: Document
view details
The Ecology of Neonatal Abstinence Syndrome
Summarizes results from an 8-state study of neonatal abstinence syndrome (NAS), a drug withdrawal condition that may occur in newborns exposed to opioids during pregnancy. Discusses correlations to rurality, unemployment rates, poverty, and the supply of healthcare providers, and identifies potential policy interventions that could help. For interactive, county-level data, see the Simulation of County Neonatal Abstinence Syndrome (NAS) Rates Tool based on study findings.
Additional links: Simulation of County Neonatal Abstinence Syndrome (NAS) Rates Tool
Date: 2019
Type: Document
Sponsoring organization: RAND Corporation
view details
Patterns of Buprenorphine Use and Risk for Re-Arrest among Highly Vulnerable Opioid-Involved Women Released from Jails in Rural Appalachia
Study examining licit and illicit use of buprenorphine by women in the Appalachia region of Kentucky with moderate to severe opioid involvement who had recently been released from jail. Discusses the role of consistent healthcare services in relation to risk for re-arrest, presenting data on demographics, opioid use, and healthcare access over a 3-month tracking period.
Author(s): Hilary L. Surratt, Michele Staton, Carl G. Leukefeld, Carrie B. Oser, J. Matthew Webster
Citation: Journal of Addictive Diseases, 37(1-2), 1-4
Date: 12/2018
Type: Document
view details